Growth Metrics

Ocugen (OCGN) EPS (Weighted Average and Diluted): 2017-2025

Historic EPS (Weighted Average and Diluted) for Ocugen (OCGN) over the last 6 years, with Sep 2025 value amounting to -$0.07.

  • Ocugen's EPS (Weighted Average and Diluted) fell 40.00% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.13, marking a year-over-year increase of 86.02%. This contributed to the annual value of -$0.80 for FY2024, which is 207.69% down from last year.
  • Latest data reveals that Ocugen reported EPS (Weighted Average and Diluted) of -$0.07 as of Q3 2025, which was down 40.00% from -$0.05 recorded in Q2 2025.
  • Ocugen's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.04 during Q4 2024, with a 5-year trough of -$0.46 in Q1 2024.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.12, with a median of -$0.05 in 2025.
  • The largest annual percentage gain for Ocugen's EPS (Weighted Average and Diluted) in the last 5 years was 200.00% (2024), contrasted with its biggest fall of 475.00% (2024).
  • Ocugen's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.07 in 2021, then crashed by 42.86% to -$0.10 in 2022, then spiked by 60.00% to -$0.04 in 2023, then spiked by 200.00% to $0.04 in 2024, then tumbled by 40.00% to -$0.07 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.07 in Q3 2025, compared to -$0.05 in Q2 2025 and -$0.05 in Q1 2025.